Monica M. Bertagnolli

National Institutes of Health — United States

Medicine · Health Sciences

75h-index26.6kcitations460works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(131), Inflammatory mediators and NSAID effects(97), Genetic factors in colorectal cancer(85), Cancer Genomics and Diagnostics(59), Estrogen and related hormone effects(43)

Publications460 total

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy
UNC Libraries·2025Open Access
Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)
UNC Libraries·2025Open Access
Genome‐wide association studies of survival in 1520 cancer patients treated with bevacizumab‐containing regimens
UNC Libraries·2025Open Access
Modernizing Research and Evidence Consensus Definitions
JAMA Network Open·2025· 4 citedOpen Access
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients
UNC Libraries·2025Open Access
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients
UNC Libraries·2025Open Access
Novel treatment-specific causal biomarkers for colorectal cancer by omics integration
NAR Genomics and Bioinformatics·2025Open Access
A Unified Approach to Health Data Exchange
JAMA·2025· 15 citedOpen Access
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy
Communications Medicine·2025· 5 citedOpen Access
Recent Developments in Women’s Health Research at the US National Institutes of Health
JAMA·2025· 5 cited
How the US National Institutes of Health is confronting health threats in a changing world
The Lancet·2024
The Oncology QCARD Initiative: Fostering efficient evaluation of initial real‐world data proposals
UNC Libraries·2024· 1 citedOpen Access
The Oncology <scp>QCARD</scp> Initiative: Fostering efficient evaluation of initial real‐world data proposals
Pharmacoepidemiology and Drug Safety·2024· 5 citedOpen Access
Opportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and U.S. Food and Drug Administration
Annals of Internal Medicine·2024· 3 cited
Applied research won’t flourish without basic science
eLife·2024· 3 citedOpen Access
High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance
Communications Medicine·2024· 9 citedOpen Access
Connecting lab, clinic, and community
Science·2024· 5 cited
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies
2024· 2 citedOpen Access
Supplementary Figure 1 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma
2024Open Access
Data from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma
2024Open Access
page 1 of 23Next →

Frequent Co-authors

Donna Niedzwiecki(16), Richard M. Goldberg(16), Robert J. Mayer(12), Alan P. Venook(10), Jeffrey A. Meyerhardt(8), Charles D. Blanke(8), Mark Redston(6), Chandrajit P. Raut(6), Carolyn C. Compton(6), Robert S. Warren(6), Ernest T. Hawk(5), Heinz‐Josef Lenz(5), Federico Innocenti(5), Eileen M. O’Reilly(5), Howard S. Höchster(5), Richard L. Schilsky(5), Suzanne George(5), Leonard B. Saltz(5), Scott D. Solomon(4), Janet Wittes(4)